ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,153.90
      1.55%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      03/01/20195:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20195:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/01/20198:00AMGlobeNewswire Inc.CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults With Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20195:26PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/15/20196:19AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/201911:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/13/201912:06PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20196:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/08/20195:57PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/29/20196:14PMBusiness WireFederman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20197:56PMDow Jones NewsSanofi/Lexicon Diabetes Drug Gets 8-8 Vote From FDA Panel -- UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20197:27PMDow Jones NewsSanofi/Lexicon Diabetes Drug Gets 8-8 Vote From FDA PanelNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20196:20PMGlobeNewswire Inc.FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20196:20PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee ...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20197:45AMDow Jones NewsLexicon Stock Halted Thursday Pending FDA MeetingNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/17/20197:05AMGlobeNewswire Inc.Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for t...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/21/201812:45PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/20/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/18/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX